Day One Biopharmaceuticals, Inc.
DAWN
$6.30
-$0.69-9.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.00M | -65.71M | 37.04M | -4.41M | -62.41M |
| Total Depreciation and Amortization | 894.00K | 759.00K | 746.00K | 408.00K | 116.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.61M | 8.21M | 65.18M | -95.87M | 11.35M |
| Change in Net Operating Assets | -32.51M | 26.74M | -52.21M | 50.74M | 1.22M |
| Cash from Operations | -59.00M | -30.01M | 50.75M | -49.13M | -49.73M |
| Capital Expenditure | -317.00K | -1.42M | -724.00K | -26.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.30M | -268.22M | -66.98M | 17.08M | 89.29M |
| Cash from Investing | -32.61M | -269.64M | -67.70M | 17.06M | 89.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1.85M | 179.15M | 1.30M | 48.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 20.94M | -- | -- |
| Cash from Financing | -- | 1.85M | 200.10M | 1.30M | 48.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.61M | -297.80M | 183.15M | -30.78M | 39.61M |